Mesenchymal stem cells: Will they have a role in the clinic?
- 16 May 2002
- journal article
- review article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 85 (S38) , 73-79
- https://doi.org/10.1002/jcb.10046
Abstract
In addition to hematopoietic stem cells (HSC), human post natal bone marrow contains another stem cell capable of giving rise to multiple mesenchymal cell lineages. Termed mesenchymal stem cells (MSCs) based on their capacity for multi‐lineage differentiation, these cells can easily be obtained following a simple bone marrow aspiration procedure and subsequently expanded in culture through as many as 50 population doublings. This extensive capacity for expansion in vitro at clinical scale has recently facilitated the development of clinical trials designed to assess the safety, feasibility, and efficacy of transplanting MSC for a variety of pathological conditions. This review focuses on the background and rationale for performing clinical studies of MSC transplantation and will discuss the potential role that MSC may play in the correction or modification of human diseases. J. Cell. Biochem. Suppl. 38: 73–79, 2002.Keywords
This publication has 27 references indexed in Scilit:
- Baboon Mesenchymal Stem Cells Can Be Genetically Modified to Secrete Human ErythropoietinIn VivoHuman Gene Therapy, 2001
- Bone Marrow Stromal Stem Cells: Nature, Biology, and Potential ApplicationsThe International Journal of Cell Cloning, 2001
- Mesenchymal stem cellsExperimental Hematology, 2000
- Marrow stromal stem cellsJournal of Clinical Investigation, 2000
- Bone marrow–derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseasesExperimental Hematology, 1999
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999
- Muscle Regeneration by Bone Marrow-Derived Myogenic ProgenitorsScience, 1998
- LacZ and Interleukin-3 ExpressionIn Vivoafter Retroviral Transduction of Marrow-Derived Human Osteogenic Mesenchymal ProgenitorsHuman Gene Therapy, 1997
- Systemic Delivery of Human Growth Hormone or Human Factor IX in Dogs by Reintroduced Genetically Modified Autologous Bone Marrow Stromal CellsHuman Gene Therapy, 1997
- HETEROTOPIC TRANSPLANTS OF BONE MARROWTransplantation, 1968